CD69 and colorectal carcinoma: To assess natural killer cell activation by virotherapy, we cocultured NK cells with MV-infected colorectal cancer (CRC) and pancreatic adenocarcinoma (PDAC) cells and analyzed expression of the early activation marker CD69 (Fig. 1A(i)).